204 related articles for article (PubMed ID: 16954505)
1. KLF4 suppresses transformation of pre-B cells by ABL oncogenes.
Kharas MG; Yusuf I; Scarfone VM; Yang VW; Segre JA; Huettner CS; Fruman DA
Blood; 2007 Jan; 109(2):747-55. PubMed ID: 16954505
[TBL] [Abstract][Full Text] [Related]
2. The signaling axis atypical protein kinase C λ/ι-Satb2 mediates leukemic transformation of B-cell progenitors.
Nayak RC; Hegde S; Althoff MJ; Wellendorf AM; Mohmoud F; Perentesis J; Reina-Campos M; Reynaud D; Zheng Y; Diaz-Meco MT; Moscat J; Cancelas JA
Nat Commun; 2019 Jan; 10(1):46. PubMed ID: 30610188
[TBL] [Abstract][Full Text] [Related]
3. A member of Forkhead transcription factor FKHRL1 is a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells.
Komatsu N; Watanabe T; Uchida M; Mori M; Kirito K; Kikuchi S; Liu Q; Tauchi T; Miyazawa K; Endo H; Nagai T; Ozawa K
J Biol Chem; 2003 Feb; 278(8):6411-9. PubMed ID: 12456669
[TBL] [Abstract][Full Text] [Related]
4. Pim-1 and Pim-2 kinases are required for efficient pre-B-cell transformation by v-Abl oncogene.
Chen JL; Limnander A; Rothman PB
Blood; 2008 Feb; 111(3):1677-85. PubMed ID: 18042805
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of krüppel-like factor 4 facilitates carcinogenesis by inducing g1/s phase arrest in clear cell renal cell carcinoma.
Song E; Ma X; Li H; Zhang P; Ni D; Chen W; Gao Y; Fan Y; Pang H; Shi T; Ding Q; Wang B; Zhang Y; Zhang X
PLoS One; 2013; 8(7):e67758. PubMed ID: 23861801
[TBL] [Abstract][Full Text] [Related]
6. Role of
Choi H; Roh J
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587813
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta1 sensitivity is altered in Abl-Myc- and Raf-Myc-induced mouse pre-B-cell tumors.
Letterio J; Rudikoff E; Voong N; Bauer SR
Stem Cells; 2006 Dec; 24(12):2611-7. PubMed ID: 16945999
[TBL] [Abstract][Full Text] [Related]
8. Krüppel-like factor 4 regulates B cell number and activation-induced B cell proliferation.
Klaewsongkram J; Yang Y; Golech S; Katz J; Kaestner KH; Weng NP
J Immunol; 2007 Oct; 179(7):4679-84. PubMed ID: 17878366
[TBL] [Abstract][Full Text] [Related]
9. Phosphoinositide 3-kinase signaling is essential for ABL oncogene-mediated transformation of B-lineage cells.
Kharas MG; Deane JA; Wong S; O'Bosky KR; Rosenberg N; Witte ON; Fruman DA
Blood; 2004 Jun; 103(11):4268-75. PubMed ID: 14976048
[TBL] [Abstract][Full Text] [Related]
10. KLF4 is a FOXO target gene that suppresses B cell proliferation.
Yusuf I; Kharas MG; Chen J; Peralta RQ; Maruniak A; Sareen P; Yang VW; Kaestner KH; Fruman DA
Int Immunol; 2008 May; 20(5):671-81. PubMed ID: 18375530
[TBL] [Abstract][Full Text] [Related]
11. Loss of Pax5 Exploits Sca1-BCR-ABL
Martín-Lorenzo A; Auer F; Chan LN; García-Ramírez I; González-Herrero I; Rodríguez-Hernández G; Bartenhagen C; Dugas M; Gombert M; Ginzel S; Blanco O; Orfao A; Alonso-López D; Rivas JL; García-Cenador MB; García-Criado FJ; Müschen M; Sánchez-García I; Borkhardt A; Vicente-Dueñas C; Hauer J
Cancer Res; 2018 May; 78(10):2669-2679. PubMed ID: 29490943
[TBL] [Abstract][Full Text] [Related]
12. Acetylbritannilactone suppresses growth via upregulation of krüppel-like transcription factor 4 expression in HT-29 colorectal cancer cells.
Fang XM; Liu B; Liu YB; Wang JJ; Wen JK; Li BH; Han M
Oncol Rep; 2011 Nov; 26(5):1181-7. PubMed ID: 21811764
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor activity of SOCS-1.
Rottapel R; Ilangumaran S; Neale C; La Rose J; Ho JM; Nguyen MH; Barber D; Dubreuil P; de Sepulveda P
Oncogene; 2002 Jun; 21(28):4351-62. PubMed ID: 12080466
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes.
Li W; Jiang Z; Li T; Wei X; Zheng Y; Wu D; Yang L; Chen S; Xu B; Zhong M; Jiang J; Hu Y; Su H; Zhang M; Huang X; Geng S; Weng J; Du X; Liu P; Li Y; Liu H; Yao Y; Li P
Mol Cancer; 2015 Feb; 14():26. PubMed ID: 25644173
[TBL] [Abstract][Full Text] [Related]
15. p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant to induce pre-B lymphoma in vivo.
Zou X; Cong F; Coutts M; Cattoretti G; Goff SP; Calame K
Mol Cell Biol; 2000 Jan; 20(2):628-33. PubMed ID: 10611241
[TBL] [Abstract][Full Text] [Related]
16. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
Gross AW; Ren R
Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
[TBL] [Abstract][Full Text] [Related]
17. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression.
Tomoda K; Kato JY; Tatsumi E; Takahashi T; Matsuo Y; Yoneda-Kato N
Blood; 2005 Jan; 105(2):775-83. PubMed ID: 15353483
[TBL] [Abstract][Full Text] [Related]
18. FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism.
Fernández de Mattos S; Essafi A; Soeiro I; Pietersen AM; Birkenkamp KU; Edwards CS; Martino A; Nelson BH; Francis JM; Jones MC; Brosens JJ; Coffer PJ; Lam EW
Mol Cell Biol; 2004 Nov; 24(22):10058-71. PubMed ID: 15509806
[TBL] [Abstract][Full Text] [Related]
19. v-Abl signaling disrupts SOCS-1 function in transformed pre-B cells.
Limnander A; Danial NN; Rothman PB
Mol Cell; 2004 Aug; 15(3):329-41. PubMed ID: 15304214
[TBL] [Abstract][Full Text] [Related]
20. Perillyl alcohol induces c-Myc-dependent apoptosis in Bcr/Abl-transformed leukemia cells.
Clark SS
Oncology; 2006; 70(1):13-8. PubMed ID: 16439861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
